Michael Khadavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Khadavi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Lavigne
Department of Medicine, Université de Montreal, Montreal, Quebec, Canada
4 shared publications - Andrew Hiett
Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center, Kansas City, KS, USA
1 shared publication - Ann Wingard
Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center, Kansas City, KS, USA
1 shared publication - Arthur Jason De Luigi
Department of Sports Medicine Hall of Fame Sports, LLC Scottsdale Arizona USA
1 shared publication Berdale S. Colorado
Department of Physical Medicine and Rehabilitation University of Alabama at Birmingham Birmingham Alabama USA
1 shared publication- Brennan J. Boettcher
Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA
1 shared publication
Latest Publications
- Open Access
- 19 August 2026
- Published by Wiley in Journal of Clinical Ultrasound
Ultrasound‐Guided Fasciotomy for Chronic Exertional Compartment Syndrome: A Case Report With Long‐Term Sonographic Outcomes
We report the case of a 38‐year‐old recreational female runner with anterior and lateral chronic exertional compartment syndrome treated with ultrasound‐guided fasciotomy using a V‐shaped meniscotome. She began her return‐to‐run protocol 8 days postprocedure and achieved full symptom resolution. At 6 months, ultrasound revealed persistent fascial separation without complications, representing the first report of long‐term sonographic outcomes following fasciotomy for chronic exertional compartment syndrome. These findings support further prospective studies to evaluate the clinical and sonographic outcomes of this technique.
- 19 August 2026
- Published by Wiley in Journal of Clinical Ultrasound
Open AccessUltrasound‐Guided Fasciotomy for Chronic Exertional Compartment Syndrome: A Case Report With Long‐Term Sonographic Outcomes
We report the case of a 38‐year‐old recreational female runner with anterior and lateral chronic exertional compartment syndrome treated with ultrasound‐guided fasciotomy using a V‐shaped meniscotome. She began her return‐to‐run protocol 8 days postprocedure and achieved full symptom resolution. At 6 months, ultrasound revealed persistent fascial separation without complications, representing the first report of long‐term sonographic outcomes following fasciotomy for chronic exertional compartment syndrome. These findings support further prospective studies to evaluate the clinical and sonographic outcomes of this technique.
AAPM &R guidance statement on platelet rich plasma for knee osteoarthritis
Background: The current nonoperative standard‐of‐care therapies for knee osteoarthritis (OA) include weight reduction, physical therapy, analgesics, optimization of biomechanics, and intra‐articular injection of corticosteroids. Platelet rich plasma (PRP) is an orthobiologic intervention that is increasingly used in patients with knee OA, primarily due to its many key mediators that can potentially reduce joint inflammation thereby improving pain and enhancing overall joint function. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) convened a technical expert panel (TEP) to summarize and assess the evidence for use of PRP in patients with knee OA and synthesize current knowledge into a summary document that can serve as a resource for clinicians. We address many of the questions and decision points that practitioners need to consider for responsible use of PRP in knee OA. Objective: To develop consensus‐based practice recommendations to identify and address gaps in PRP applications in patients with knee OA. Methods: The AAPM&R orthobiologic TEP initiated development of this consensus guidance statement in March 2023. The TEP was responsible for formulating search terms and research questions and synthesizing evidence obtained from a structured literature review that was initially completed in April 2023 and subsequently updated to reflect studies published between May 2023 and June 2025. The recommended actions and best practices in this guidance reflect consensus being achieved by the expert physiatrists and supported by best available evidence, where available. These actions and practices were conceptualized in response to common questions this expert panel frequently encounter in the use and administration of PRP. The TEP was asked to consider the strengths and limitations of available evidence and augment with expert opinion focused on closing knowledge gaps guiding the delivery of PRP in patients with knee OA. Results: As a result of the structured literature review and use of a modified Delphi process to achieve consensus on clinical guidance for PRP use in patients with knee OA, the AAPM&R TEP on use of PRP in knee OA arrived at five evidence‐based clinical recommendations for PRP management and 11 consensus‐based best practices supported by expert opinion and limited evidence. Conclusion: This consensus guidance addresses common questions about the use of PRP in patients with knee OA and provides actionable recommendations and best practices based on expert opinion supported by best available evidence. Despite their growing availability as point‐of‐care interventions, orthobiologic therapies remain an evolving area of practice. Robust, dose‐dependent randomized controlled trials are needed to more clearly establish the clinical effects of PRP on patient outcomes. Clinical judgment should be exercised and management options tailored to individual patient needs, preferences, and risk profiles.
AAPM &R guidance statement on platelet rich plasma for knee osteoarthritis
Background: The current nonoperative standard‐of‐care therapies for knee osteoarthritis (OA) include weight reduction, physical therapy, analgesics, optimization of biomechanics, and intra‐articular injection of corticosteroids. Platelet rich plasma (PRP) is an orthobiologic intervention that is increasingly used in patients with knee OA, primarily due to its many key mediators that can potentially reduce joint inflammation thereby improving pain and enhancing overall joint function. The American Academy of Physical Medicine and Rehabilitation (AAPM&R) convened a technical expert panel (TEP) to summarize and assess the evidence for use of PRP in patients with knee OA and synthesize current knowledge into a summary document that can serve as a resource for clinicians. We address many of the questions and decision points that practitioners need to consider for responsible use of PRP in knee OA. Objective: To develop consensus‐based practice recommendations to identify and address gaps in PRP applications in patients with knee OA. Methods: The AAPM&R orthobiologic TEP initiated development of this consensus guidance statement in March 2023. The TEP was responsible for formulating search terms and research questions and synthesizing evidence obtained from a structured literature review that was initially completed in April 2023 and subsequently updated to reflect studies published between May 2023 and June 2025. The recommended actions and best practices in this guidance reflect consensus being achieved by the expert physiatrists and supported by best available evidence, where available. These actions and practices were conceptualized in response to common questions this expert panel frequently encounter in the use and administration of PRP. The TEP was asked to consider the strengths and limitations of available evidence and augment with expert opinion focused on closing knowledge gaps guiding the delivery of PRP in patients with knee OA. Results: As a result of the structured literature review and use of a modified Delphi process to achieve consensus on clinical guidance for PRP use in patients with knee OA, the AAPM&R TEP on use of PRP in knee OA arrived at five evidence‐based clinical recommendations for PRP management and 11 consensus‐based best practices supported by expert opinion and limited evidence. Conclusion: This consensus guidance addresses common questions about the use of PRP in patients with knee OA and provides actionable recommendations and best practices based on expert opinion supported by best available evidence. Despite their growing availability as point‐of‐care interventions, orthobiologic therapies remain an evolving area of practice. Robust, dose‐dependent randomized controlled trials are needed to more clearly establish the clinical effects of PRP on patient outcomes. Clinical judgment should be exercised and management options tailored to individual patient needs, preferences, and risk profiles.
- Open Access
- 16 October 2025
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 53 (2) , 227-234
Ultrasound-guided Achilles tendon rupture repair using knotless barbed suture: a cadaveric study
Purpose: To describe a novel, minimally invasive, ultrasound-guided Achilles tendon repair technique using a knotless barbed suture and to assess its feasibility in a cadaveric model. Methods: A midportion Achilles tendon rupture was simulated in a Thiel-embalmed cadaver. The tendon was repaired percutaneously under ultrasound guidance using a 0.6-mm USP 1 knotless barbed suture mounted on a 19-gauge, 3.5-inch curved needle. The needle was advanced intratendinously under continuous ultrasound guidance. Tendon reapproximation was assessed with ultrasound and confirmed by anatomical dissection. The resting plantar flexion angle was measured before and after the repair. Results: The Achilles tendon repair technique resulted in successful reapproximation of the tendon ends with anatomic alignment. Post-repair ultrasound and dissection confirmed accurate intratendinous suture placement and full tendon continuity. The resting plantar flexion angle increased from 23° to 50° after the repair. Conclusion: This is the first report of an ultrasound-guided Achilles tendon repair using a knotless barbed suture. The technique appears feasible in a cadaveric model and may represent a promising minimally invasive option for patients requiring improved tendon approximation. Its office-based approach may reduce surgical risks associated with conventional repair and tendon elongation seen with conservative treatment. Further biomechanical and clinical studies are warranted to evaluate its safety, durability, and functional outcomes.
- 16 October 2025
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 53 (2) , 227-234
Open AccessUltrasound-guided Achilles tendon rupture repair using knotless barbed suture: a cadaveric study
Purpose: To describe a novel, minimally invasive, ultrasound-guided Achilles tendon repair technique using a knotless barbed suture and to assess its feasibility in a cadaveric model. Methods: A midportion Achilles tendon rupture was simulated in a Thiel-embalmed cadaver. The tendon was repaired percutaneously under ultrasound guidance using a 0.6-mm USP 1 knotless barbed suture mounted on a 19-gauge, 3.5-inch curved needle. The needle was advanced intratendinously under continuous ultrasound guidance. Tendon reapproximation was assessed with ultrasound and confirmed by anatomical dissection. The resting plantar flexion angle was measured before and after the repair. Results: The Achilles tendon repair technique resulted in successful reapproximation of the tendon ends with anatomic alignment. Post-repair ultrasound and dissection confirmed accurate intratendinous suture placement and full tendon continuity. The resting plantar flexion angle increased from 23° to 50° after the repair. Conclusion: This is the first report of an ultrasound-guided Achilles tendon repair using a knotless barbed suture. The technique appears feasible in a cadaveric model and may represent a promising minimally invasive option for patients requiring improved tendon approximation. Its office-based approach may reduce surgical risks associated with conventional repair and tendon elongation seen with conservative treatment. Further biomechanical and clinical studies are warranted to evaluate its safety, durability, and functional outcomes.
- Open Access
- 13 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (1) , 3-10
Current evidence on hyaluronic acid injections for rotator cuff tendinopathy: A scoping review
Introduction: There is growing evidence that hyaluronic acid (HA) injections can significantly improve pain and function in rotator cuff tendinopathy. However, there is no consensus regarding the optimal parameters for HA injections. This narrative review explores the procedural considerations for HA injections in rotator cuff tendinopathy. Methods: A literature search using Pubmed and Cochrane was conducted to assess procedural considerations for HA injections in rotator cuff tendinopathy including the type of HA (linear vs. cross-linked), the molecular weight (low, moderate, and high), the combination of HA with other products, the number and frequency of injections, the injection guidance, and the adverse effects. Results: Nine randomized-controlled trials and two prospective non-randomized studies assessed the efficacy of HA injections for rotator cuff tendinopathy, and their characteristics were thoroughly analyzed. Two studies compared the efficacy of different molecular weight HA. One study assessed the efficacy of HA combined with extracorporeal shockwave therapy. Conclusion: Highlights of the findings include the clinical benefits of HA injections for rotator cuff tendinopathy, the better tolerability of low molecular weight HA compared to high molecular weight, the safer adverse effect profile of HA compared to glucocorticoid injections, and the synergistic effect of HA and extracorporeal shockwave therapy.
- 13 March 2025
- Published by SAGE Publications in Shoulder & Elbow
- Vol. 18 (1) , 3-10
Open AccessCurrent evidence on hyaluronic acid injections for rotator cuff tendinopathy: A scoping review
Introduction: There is growing evidence that hyaluronic acid (HA) injections can significantly improve pain and function in rotator cuff tendinopathy. However, there is no consensus regarding the optimal parameters for HA injections. This narrative review explores the procedural considerations for HA injections in rotator cuff tendinopathy. Methods: A literature search using Pubmed and Cochrane was conducted to assess procedural considerations for HA injections in rotator cuff tendinopathy including the type of HA (linear vs. cross-linked), the molecular weight (low, moderate, and high), the combination of HA with other products, the number and frequency of injections, the injection guidance, and the adverse effects. Results: Nine randomized-controlled trials and two prospective non-randomized studies assessed the efficacy of HA injections for rotator cuff tendinopathy, and their characteristics were thoroughly analyzed. Two studies compared the efficacy of different molecular weight HA. One study assessed the efficacy of HA combined with extracorporeal shockwave therapy. Conclusion: Highlights of the findings include the clinical benefits of HA injections for rotator cuff tendinopathy, the better tolerability of low molecular weight HA compared to high molecular weight, the safer adverse effect profile of HA compared to glucocorticoid injections, and the synergistic effect of HA and extracorporeal shockwave therapy.
- Open Access
- 1 January 2025
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 13 (3)
Debride, Refill, Fertilize: Technique Description with Corresponding Case Report of a Novel, Minimally Invasive Treatment for Achilles Tendon Partial Tears
Treatment of midportion Achilles tendinopathy and partial tear pathology is particularly challenging, with surgical treatments characterized by prolonged recoveries, modest outcomes, and up to 11% complication rate, while more recent minimally invasive strategies including percutaneous tenotomy, platelet-rich plasma injection, and tendon hydrodissection have at best demonstrated mixed results. We hypothesize that failures from available surgical and minimally invasive treatments occur because they address only part of the pathology (e.g., orthobiologics focused on promoting tendon growth without addressing the burden of diseased, degenerative tendon tissue). Similarly, percutaneous or surgical debridement while removing pathologic tissue unfortunately leaves large voids in the tendon with hopes of creating a vascular and healing response that will fill the void. Herein, we present a novel multifaceted approach with a corresponding case report of three sequential, minimally invasive therapies utilizing unique yet complimentary mechanisms of action: debridement with percutaneous ultrasonic tenotomy, tissue void grafting with allograft connective tissue matrix, and promotion of tendon repair/regeneration with harvested bone marrow concentrate. This case is of a 39-year-old male recreational athlete who failed two years of conservative care and orthobiologic injections for his midportion Achilles tendinopathy and partial tear. Following treatment with percutaneous ultrasonic tenotomy and injection of allograft connective tissue matrix along with autologous bone marrow concentrate, he returned to most athletic activities by three months and ultimately achieved a full asymptomatic and functional recovery by six months with complete healing of his partial tendon tear on follow-up magnetic resonance imaging.
- 1 January 2025
- Published by Knowledge Enterprise Journals in Medical Research Archives
- Vol. 13 (3)
Open AccessDebride, Refill, Fertilize: Technique Description with Corresponding Case Report of a Novel, Minimally Invasive Treatment for Achilles Tendon Partial Tears
Treatment of midportion Achilles tendinopathy and partial tear pathology is particularly challenging, with surgical treatments characterized by prolonged recoveries, modest outcomes, and up to 11% complication rate, while more recent minimally invasive strategies including percutaneous tenotomy, platelet-rich plasma injection, and tendon hydrodissection have at best demonstrated mixed results. We hypothesize that failures from available surgical and minimally invasive treatments occur because they address only part of the pathology (e.g., orthobiologics focused on promoting tendon growth without addressing the burden of diseased, degenerative tendon tissue). Similarly, percutaneous or surgical debridement while removing pathologic tissue unfortunately leaves large voids in the tendon with hopes of creating a vascular and healing response that will fill the void. Herein, we present a novel multifaceted approach with a corresponding case report of three sequential, minimally invasive therapies utilizing unique yet complimentary mechanisms of action: debridement with percutaneous ultrasonic tenotomy, tissue void grafting with allograft connective tissue matrix, and promotion of tendon repair/regeneration with harvested bone marrow concentrate. This case is of a 39-year-old male recreational athlete who failed two years of conservative care and orthobiologic injections for his midportion Achilles tendinopathy and partial tear. Following treatment with percutaneous ultrasonic tenotomy and injection of allograft connective tissue matrix along with autologous bone marrow concentrate, he returned to most athletic activities by three months and ultimately achieved a full asymptomatic and functional recovery by six months with complete healing of his partial tendon tear on follow-up magnetic resonance imaging.